Tri Locum Partners, a New York-based hedge fund manager, was formed in November 2019 by Prashanth Jayaram, a former portfolio manager at Citadel. The firm aims to generate risk-adjusted returns in all market and economic conditions by employing a long/short strategy focused on innovation in the healthcare sector, including biotechnology, pharmaceuticals, services, and medical devices.
Prashanth Jayaram, the founder of Tri Locum Partners LP and BioWizard, Inc., serves as Managing Partner & Chief Investment Officer of Tri Locum Partners. His extensive background includes roles as an Analyst at Maverick Capital Ltd., Healthcare Analyst and Portfolio Manager at Citadel Advisors LLC, Analyst at Morgan Stanley & Co. LLC, Associate at McKinsey & Co., Inc., Analyst at Sanford C. Bernstein & Co. LLC, and Portfolio Manager at Millennium Management LLC. Dr. Jayaram holds undergraduate and MBA degrees from the University of Pennsylvania.
As of March 2024, Tri Locum Partners manages discretionary assets totaling $357,536,952 for 5 clients. Their latest 13F filing for Q1 2024 reported $288,365,187 in managed 13F securities, with a top 10 holdings concentration of 62.41%. The firm's largest holding is Teva Pharmaceutical Industries Ltd, ADR, with 2,216,188 shares.
